Ftse Mib
33.464,64
-0,09%
DAX
19.405,20
0,51%
S&P 500
5.980,67
0,19%
NASDAQ
19.043,40
0,21%
Bitcoin
94.958,56
-3,14%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Phio Pharmaceuticals Corporation (PHIO) Phio Pharmaceuticals Corporation (PHIO) Notizie

Phio Pharmaceuticals Corporation

PHIO
2,45
-0,02 (-0,81%)
Ultimo aggiornamento: 20:56:53
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
14/11/202422:49EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202422:47EDGAR2Form 8-K - Current report
13/11/202417:20EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
07/11/202416:21EDGAR2Form 8-K - Current report
13/9/202421:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202420:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202422:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202422:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202423:00EDGAR2Form 8-K - Current report
14/8/202422:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202415:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/8/202414:00EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
01/8/202414:00EDGAR2Form 8-K - Current report
26/7/202422:30EDGAR2Form S-1 - General form for registration of securities under..
24/7/202422:30EDGAR2Form 8-K - Current report
28/5/202423:00EDGAR2Form 8-K - Current report
20/5/202423:03EDGAR2Form S-3 - Registration statement under Securities Act of..
20/5/202422:59EDGAR2Form RW - Registration Withdrawal Request
17/5/202422:45EDGAR2Form S-3 - Registration statement under Securities Act of..
17/5/202415:04EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17/5/202415:00GLOBEPhio Pharmaceuticals Secures New Investor
17/5/202415:00EDGAR2Form 8-K - Current report
16/5/202414:00GLOBEPhio Pharmaceuticals Presents This Week at the Society for..
15/5/202419:00GLOBEPhio Pharmaceuticals Announces Completion of Dosing in First..
09/5/202423:25GLOBEPhio Pharmaceuticals Reports Q1 2024 Results and Provides..
09/5/202423:23EDGAR2Form 8-K - Current report
09/5/202423:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202423:04EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
08/5/202423:02EDGAR2Form DEF 14A - Other definitive proxy statements
30/4/202413:30GLOBEPhio Pharmaceuticals Announces Upcoming Presentation at the..
22/4/202419:10GLOBEIntratumoral Injection of Phio’s PH-762 significantly..
16/4/202413:30GLOBEPhio Pharmaceuticals Announces Upcoming Presentations at the..
11/4/202413:30GLOBEPhio Pharmaceuticals Announces Upcoming Presentation at the..
03/4/202413:30GLOBENational Spotlight Features Phio’s Innovative RNAi..
02/4/202413:30GLOBEPhio Pharmaceuticals Reports 2023 Year End Financial Results..
21/3/202412:30GLOBEPhio Pharmaceuticals Presenting Data Showing INTASYL May..
13/3/202419:00GLOBEPhio Pharmaceuticals Announces Addition of Clinical Trial..
06/3/202416:30GLOBEPhio Pharmaceuticals Announces Patent Granted by USPTO,..
06/3/202401:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202401:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202416:30EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31/1/202414:00GLOBEPhio Pharmaceuticals Announces Data Showing INTASYL May..
26/1/202423:00EDGAR2Form 8-K - Current report
28/12/202315:13EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
19/12/202322:52EDGAR2Form S-1 - General form for registration of securities under..
08/12/202323:00EDGAR2Form 8-K - Current report
07/12/202314:00GLOBEPhio Pharmaceuticals Announces Exercise of Warrants for $2.8..
Apertura: 2,57 Min: 2,4214 Max: 2,57
Chiusura: 2,47

La tua Cronologia

NASDAQ
PHIO
Phio Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network